Intrathecal interferon for multiple sclerosis.

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Science

• Publication date

  1982-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.1982.00510220007002PMID 17814466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon therapy in Hodgkin's disease. A case report.

  2009cited by this paper
• The potassium effect.

  1982cited by this paper
• Nerves, myelin and multiple sclerosis

  1981cited by this paper
• Intrathecal use of interferon in encephalitis.

  1981cited by this paper
• Intrathecal interferon reduces exacerbations of multiple sclerosis.

  1981cited by this paper
• Intrathecal interferon in meningeal leukemia.

  1981cited by this paper
• Changes in immune response during relapses in MS patients

  1981cited by this paper
• Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.

  1980cited by this paper
• Epstein-Barr virus antibodies in multiple sclerosis.

  1980cited by this paper
• Multiple sclerosis and viruses

  1980cited by this paper
• Defective immunoreguktion in multiple sclerosis

  1980cited by this paper
• Session on Multiple Sclerosis/Immunology Morning Meeting Thursday, April 26, 1979

  1979cited by this paper
• The design of clinical studies to assess therapeutic efficacy in multiple sclerosis

  1979cited by this paper
• Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root.

  1979cited by this paper
• Clinical trials with exogenous interferon: summary of a meeting.

  1979cited by this paper
• The Interferon System

  1979cited by this paper
• Interferons: rationale for clinical trials in neoplastic disease.

  1979cited by this paper
• Acute demyelinating disease in a chimpanzee three years after inoculation of brain cells from a patient with MS

  1979cited by this paper
• Cytomegalovirus Isolation from a Chimpanzee with Acute Demyelinating Disease After Inoculation of Multiple Sclerosis Brain Cells

  1979cited by this paper
• Human leukocyte interferon for the treatment of herpes zoster in patients with cancer.

  1978cited by this paper
• Human fibroblast interferon in human neoplasia: clinical and laboratory study.

  1978cited by this paper
• Aging in vitro and large-scale interferon production by 15 new strains of human diploid fibroblasts

  1978cited by this paper
• Human Leukocyte Interferon in the Treatment of Varicella in Children with Cancer: a Preliminary Controlled Trial

  1978cited by this paper
• Administration of human interferon to rabies virus-infected monkeys after exposure.

  1977cited by this paper
• Acute infections in interferon-treated patients with osteosarcoma: preliminary report of a comparative study.

  1976cited by this paper
• ADMINISTRATION OF HUMAN FIBROBLAST INTERFERON IN CHRONIC HEPATITIS-B INFECTION

  1976cited by this paper
• INTERFERON IN the SERUM and CEREBROSPINAL FLUID IN PATIENTS WITH MULTIPLE SCLEROSIS and OTHER NEUROLOGICAL DISORDERS

  1976cited by this paper
• Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis.

  1976cited by this paper
• ADMINISTRATION OF INTERFERON TO AN INFANT WITH CONGENITAL RUBELLA SYNDROME INVOLVING PERSISTENT VIREMIA AND CUTANEOUS VASCULITIS

  1976cited by this paper
• Circulating interferon in man after administration of exogenous human leukocyte interferon.

  1975cited by this paper
• Interferon Crosses Blood-Cerebrospinal Fluid Barrier in Monkeys 1

  1975cited by this paper
• Intrathecal administration of interferon in neonatal herpes.

  1975cited by this paper
• Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection.

  1974cited by this paper
• Multiple sclerosis,: A reappraisal

  1972cited by this paper
• Applied and induced interferon in the prophylaxis and treatment of leukemia.

  1970cited by this paper
• Dye Uptake Methods for Assessing Viral Cytopathogenicity and their Application to Interferon Assays

  1969cited by this paper
• Cooperative study in the evaluation of therapy in multiple sclerosis: ACTH vs placebo in acute exacerbation.

  1969cited by this paper
• PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

  1965cited by this paper
• Further notes on disability evaluation in multiple sclerosis, with scale modifications

  1965cited by this paper
• The production of interferon in brains of mice infected with an arthropod-borne virus.

  1961cited by this paper

• Developing Interferon-β as a safe in-vivo experimental-medicine model of human inflammation

  2025cites this paper
• Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives

  2024cites this paper
• EBV and multiple sclerosis: Setting the research agenda.

  2022cites this paper
• Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)

  2021cites this paper
• Interferon β in Multiple Sclerosis

  2016cites this paper
• Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis

  2016cites this paper
• The conundrum of interferon-β non-responsiveness in relapsing-remitting multiple sclerosis.

  2015cites this paper
• Traitement de troubles inflammatoires de snc

  2015cites this paper
• Neutralizing antibodies and the biological response to interferon-beta therapy

  2010cites this paper
• Antiviral drug discovery: Ten more compounds, and ten more stories (part B)

  2009cites this paper
• Sensitivity: real (interferons, odorants) and imagined (homeopathy).

  2008cites this paper
• Ingested Type I Interferon in Experimental Autoimmune Encephalomyelitis

  2005cites this paper
• Interferons in multiple sclerosis.

  2005cites this paper
• Phase I clinical trial of intralesional or intraventricular leukocyte interferon for intracranial malignancies

  2004cites this paper
• Interferon-beta in the treatment of relapsing-remitting multiple sclerosis.

  2003cites this paper
• Chapter 4 Immunology of Multiple Sclerosis

  2003cites this paper
• Interferon β‐1b in Multiple Sclerosis

  2000cites this paper
• Extended observations on MS patients treated with IM interferon-beta1a (Avonex): implications for modern MS trials and therapeutics.

  2000cites this paper
• 'Early warning systems' for identifying new healthcare technologies.

  1999cites this paper
• Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

  1996cites this paper
• Intravenöse und intrathekale Behandlung der schubförmig verlaufenden Multiplen Sklerose mit natürlichem Interferon-Beta

  1995cites this paper
• Disease Modifying Therapies for Multiple Sclerosis

  1995cites this paper
• A brief history of the use of interferons as treatment of multiple sclerosis.

  1994cites this paper
• Interferon Beta for Multiple Sclerosis

  1994cites this paper
• Treatment of Multiple Sclerosis with Interferons

  1992cites this paper
• Mechanisms of Neurotoxicity and Experimental Models

  1990cites this paper
• Viral Infections and the Blood-Brain Barrier

  1989cites this paper
• The Natural Immune System in Autoimmune and Neurological Disease

  1989cites this paper
• Aktueller Stand der Therapie mit Interferonen

  1988cites this paper
• Multiple Sclerosis: Clinical Trials with Interferons

  1988cites this paper
• Natural killer (NK) cells in chronic progressive multiple sclerosis patients treated with lymphoblastoid interferon.

  1988cites this paper
• Efficacy of Intrathecally Administered Natural Human Fibroblast Interferon as Treatment of Multiple Sclerosis

  1987cites this paper
• Intrathecally administered natural human fibroblast interferon reduces exacerbations of multiple sclerosis. Results of a multicenter, double-blind study.

  1987cites this paper
• Clinical Trials Relating to Multiple Sclerosis

  1986cites this paper
• An Update on Interferon in Infectious Diseases

  1986cites this paper
• Intrathecal interferon in the treatment of multiple sclerosis. Patient follow-up.

  1985cites this paper
• Immunological Treatments in Multiple Sclerosis: Rationale, Results and New Avenues

  1984cites this paper
• Intrathecally administered interferon in multiple sclerosis

  1984cites this paper
• Clinical Use of Interferons: Central Nervous System Disorders

  1984cites this paper
• Miscellaneous antibacterial and antiviral drugs

  1984cites this paper
• Clinical Trial of Natural Alpha Interferon in Multiple Sclerosis a

  1984cites this paper
• Electroencephalographic abnormalities in interferon encephalopathy: a preliminary report.

  1984cites this paper
• Intrathecal interferon as treatment of multiple sclerosis. A planned multicenter study.

  1983cites this paper
• Toxic effects of interferon administered intrathecally.

  1983cites this paper